|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling and Marketing Expense | |||||
| Research and development | |||||
| General and Administrative Expense | |||||
| Impairment loss on goodwill | |||||
| Impairment loss on intangibles | |||||
| Change in fair value of contingent earn-out liabilities | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest expense, net | |||||
| Gain on extinguishment of seller note | |||||
| Loss on initial issuance of equity | |||||
| Change in fair value of warrant liabilities | |||||
| Other expense, net | |||||
| Loss before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net loss | |||||
| Net loss per share, basic and diluted (in dollars per share) | |||||
| Weighted-average number of shares outstanding, basic and diluted (in shares) | |||||
Loading...